STAA Staar Surgical Co

Price (delayed)

$74.78

Market cap

$3.58B

P/E Ratio

122.59

Dividend/share

N/A

EPS

$0.61

Enterprise value

$3.41B

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are ...

Highlights
Staar Surgical's EPS has surged by 165% YoY and by 17% QoQ
Staar Surgical's net income has soared by 164% YoY and by 19% from the previous quarter

Key stats

What are the main financial stats of STAA
Market
Shares outstanding
47.81M
Market cap
$3.58B
Enterprise value
$3.41B
Valuations
Price to earnings (P/E)
122.59
Price to book (P/B)
12.92
Price to sales (P/S)
14.7
EV/EBIT
93.21
EV/EBITDA
84.51
EV/Sales
14.05
Earnings
Revenue
$242.92M
EBIT
$36.63M
EBITDA
$40.4M
Free cash flow
$18.56M
Per share
EPS
$0.61
Free cash flow per share
$0.39
Book value per share
$5.79
Revenue per share
$5.09
TBVPS
$7.31
Balance sheet
Total assets
$351.18M
Total liabilities
$74.86M
Debt
$31.86M
Equity
$276.32M
Working capital
$232.72M
Liquidity
Debt to equity
0.12
Current ratio
6.65
Quick ratio
5.83
Net debt/EBITDA
-3.99
Margins
EBITDA margin
16.6%
Gross margin
77.7%
Net margin
12%
Operating margin
15.7%
Efficiency
Return on assets
8.8%
Return on equity
11.4%
Return on invested capital
31.3%
Return on capital employed
11.8%
Return on sales
15.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

STAA stock price

How has the Staar Surgical stock price performed over time
Intraday
3.72%
1 week
17.93%
1 month
30.07%
1 year
-51.74%
YTD
-18.09%
QTD
-6.42%

Financial performance

How have Staar Surgical's revenue and profit performed over time
Revenue
$242.92M
Gross profit
$188.76M
Operating income
$38.04M
Net income
$29.11M
Gross margin
77.7%
Net margin
12%
Staar Surgical's net income has soared by 164% YoY and by 19% from the previous quarter
STAA's operating income has surged by 149% year-on-year and by 14% since the previous quarter
Staar Surgical's net margin has soared by 94% YoY and by 13% from the previous quarter
Staar Surgical's operating margin has soared by 85% YoY and by 8% from the previous quarter

Growth

What is Staar Surgical's growth rate over time

Valuation

What is Staar Surgical stock price valuation
P/E
122.59
P/B
12.92
P/S
14.7
EV/EBIT
93.21
EV/EBITDA
84.51
EV/Sales
14.05
Staar Surgical's EPS has surged by 165% YoY and by 17% QoQ
STAA's P/E is 61% below its 5-year quarterly average of 315.5 and 45% below its last 4 quarters average of 224.3
STAA's price to book (P/B) is 38% lower than its last 4 quarters average of 21.0 and 15% lower than its 5-year quarterly average of 15.2
Staar Surgical's equity has increased by 29% YoY and by 7% QoQ
The stock's price to sales (P/S) is 38% less than its last 4 quarters average of 23.9
The revenue has grown by 36% YoY and by 5% from the previous quarter

Efficiency

How efficient is Staar Surgical business performance
The ROE has soared by 100% YoY and by 12% from the previous quarter
Staar Surgical's return on assets has surged by 96% YoY and by 10% QoQ
Staar Surgical's return on sales has surged by 72% YoY and by 11% QoQ
The ROIC has soared by 50% YoY

Dividends

What is STAA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STAA.

Financial health

How did Staar Surgical financials performed over time
Staar Surgical's total liabilities has increased by 45% YoY but it has decreased by 14% from the previous quarter
The total assets is up by 32% year-on-year
Staar Surgical's debt is 88% less than its equity
The company's debt to equity has surged by 140% YoY
Staar Surgical's equity has increased by 29% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.